183 studies found for:    Open Studies | "Blood Platelet Disorders"
Show Display Options
Download search resultsDownload the search results for:
Open Studies | "Blood Platelet Disorders" (183 records)
Download Content:
Zip file readers with free trial periods: WinZip or PKZip
Rank Status Study
1 Unknown  Thrombocytopathy in Gaucher Disease Patients
Conditions: Gaucher Disease;   Thrombocytopathy
Intervention:
2 Recruiting Effects of Exercise Training on Cardiovascular Health in Middle-aged Women
Conditions: Menopause;   Cardiac Function Impaired;   Cardiovascular Diseases;   Blood Platelet Disorders;   Metabolic Diseases
Interventions: Behavioral: Yoga/Pilates;   Behavioral: Spinning
3 Recruiting A Phase Ib/II Dose-finding Study to Assess the Safety and Efficacy of LDE225 + INC424 in Patients With MF
Conditions: Primary Myelofibrosis;   Thrombocythemia, Essential;   Thrombocytosis;   Myeloproliferative Disorders;   Bone Marrow Diseases;   Hematologic Diseases;   Blood Coagulation Disorders;   Blood Platelet Disorders;   Hemorrhagic Disorders
Interventions: Drug: LDE225;   Drug: INC424
4 Not yet recruiting Use of Proteomics for the Diagnosis of a Platelet-related Bleeding Disorder
Condition: Inherited Platelet Disorders
Intervention: Other: Blood collection for platelet protein samples
5 Recruiting Safety and Efficacy of Eltrombopag at Escalated Doses
Conditions: Immune Thrombocytopenia;   Platelet Disorder
Interventions: Drug: Eltrombopag;   Drug: Placebo
6 Recruiting Eltrombopag for Inherited Thrombocytopenias
Condition: Inherited Platelet Disorder
Intervention: Drug: Eltrombopag
7 Recruiting ICON1: Treatment Decisions and Outcomes in Pediatric Refractory ITP
Condition: Immune Thrombocytopenia
Intervention: Drug: Second Line ITP agents
8 Recruiting Oral Pacritinib Versus Best Available Therapy to Treat Myelofibrosis With Thrombocytopenia
Conditions: Primary Myelofibrosis;   Post-polycythemia Vera Myelofibrosis;   Post-essential Thrombocythemia Myelofibrosis
Interventions: Drug: Pacritinib;   Drug: Best Available Therapy
9 Not yet recruiting Documentation of the Efficacy of Desmopressin Within the Context of Surgical Procedures
Condition: Platelet Dysfunction
Intervention: Drug: desmopressin
10 Recruiting Evaluation of a New Approach of the Diagnosis of Constitutional Functional Disorders of Platelets
Condition: Platelet Dysfunction
Intervention: Other: Blood punction
11 Recruiting All-Trans Retinoic Acid (ATRA) Combining Dexamethasone Versus High-dose Dexamethasone for Initial Treatment of Primary Immune Thrombocytopenia (ITP)
Conditions: Purpura;   Idiopathic Thrombocytopenic Purpura
Interventions: Drug: All-Trans Retinoid Acid(ATRA);   Drug: Dexamethasone
12 Unknown  Molecular Biology of Polycythemia and Thrombocytosis
Conditions: Polycythemia;   Thrombocytosis
Intervention:
13 Recruiting Lymphatic Anomalies Registry
Conditions: Lymphatic Malformation;   Generalized Lymphatic Anomaly (GLA);   Central Conducting Lymphatic Anomaly;   CLOVES Syndrome;   Gorham-Stout Disease ("Disappearing Bone Disease");   Blue Rubber Bleb Nevus Syndrome;   Kaposiform Lymphangiomatosis;   Kaposiform Hemangioendothelioma/Tufted Angioma;   Klippel-Trenaunay Syndrome;   Lymphangiomatosis
Intervention:
14 Unknown  Anti-D for Treating Thrombocytopenia in Adults Infected With Hepatitis C Virus With or Without HIV Co-Infection
Conditions: Thrombocytopenia;   Hepatitis C;   HIV Infections
Intervention: Drug: Anti-D
15 Recruiting Global Hemostatic Methods in Hemophilia and Von Willebrand's Disease
Conditions: Hemophilia A;   Hemophilia B;   Von Willebrand's Disease
Intervention:
16 Recruiting Complement Inhibition Using Eculizumab to Overcome Platelet Transfusion Refractoriness in Patients With Severe Thrombocytopenia
Conditions: Thrombocytopenia;   Alloimmune Platelet Refractoriness
Intervention: Drug: Eculizumab
17 Recruiting Low-dose Decitabine Versus Recombinant Human Thrombopoietin for the Treatment of Refractory Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Interventions: Drug: Decitabine;   Drug: rhTPO
18 Recruiting The International ITP Registry
Condition: Thrombocytopenia
Intervention:
19 Recruiting An Open Phase 3 Study of IV-Globulin SN Inj.10% to Treat Immune Thrombocytopenia
Condition: Immune Thrombocytopenia
Intervention: Drug: Human immunoglobulin intravenous
20 Unknown  Rituximab in Patients With Relapsed or Refractory TTP-HUS
Conditions: Thrombotic Thrombocytopenic Purpura;   Hemolytic Uremic Syndrome
Intervention: Drug: Rituximab

   Previous Page Studies Shown (1-20) Next Page (21-40) Show next page of results    Last Page
Indicates status has not been verified in more than two years